Envestnet Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
118,600
+55,887
+89% +$1.33M ﹤0.01% 2720
2025
Q4
$1.46M Sell
62,713
-36,657
-37% -$817K ﹤0.01% 3052
2025
Q3
$1.96M Sell
99,370
-2,237
-2% -$46K ﹤0.01% 2892
2025
Q2
$2.2M Buy
101,607
+23,412
+30% +$553K ﹤0.01% 2759
2025
Q1
$1.9M Buy
78,195
+13,800
+21% +$311K ﹤0.01% 2772
2024
Q4
$1.34M Buy
64,395
+39,836
+162% +$856K ﹤0.01% 2958
2024
Q3
$488K Sell
24,559
-6,919
-22% -$128K ﹤0.01% 3548
2024
Q2
$488K Buy
31,478
+1,366
+5% +$21.3K ﹤0.01% 3472
2024
Q1
$480K Sell
30,112
-6,603
-18% -$99.5K ﹤0.01% 3456
2023
Q4
$617K Buy
36,715
+13,706
+60% +$187K ﹤0.01% 3210
2023
Q3
$269K Buy
23,009
+1,120
+5% +$15K ﹤0.01% 3583
2023
Q2
$294K Buy
21,889
+3,153
+17% +$45.4K ﹤0.01% 3499
2023
Q1
$311K Buy
+18,736
New +$309K ﹤0.01% 3425

Other funds holding CPRX